Atlas Trials

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Clinical trial NCT02663271 · TERMINATED

Trial details

NCT number
NCT02663271
Sponsor
University of Florida
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma MultiformeGlioblastomaMalignant GliomaGBM
Start date
2016-12-19
Primary completion
2021-06-11
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.